- Home
- NNDM vs ALT Comparison
NNDM vs ALT Comparison
Compare NNDM & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNDM
- ALT
- Stock Information
- Founded
- NNDM 2012
- ALT 1997
- Country
- NNDM Israel
- ALT United States
- Employees
- NNDM N/A
- ALT N/A
- Industry
- NNDM Electrical Products
- ALT Biotechnology: Pharmaceutical Preparations
- Sector
- NNDM Technology
- ALT Health Care
- Exchange
- NNDM Nasdaq
- ALT Nasdaq
- Market Cap
- NNDM 460.4M
- ALT 472.3M
- IPO Year
- NNDM N/A
- ALT N/A
- Fundamental
- Price
- NNDM $2.12
- ALT $5.20
- Analyst Decision
- NNDM
- ALT Strong Buy
- Analyst Count
- NNDM 0
- ALT 8
- Target Price
- NNDM N/A
- ALT $20.83
- AVG Volume (30 Days)
- NNDM 2.1M
- ALT 2.6M
- Earning Date
- NNDM 03-20-2025
- ALT 05-08-2025
- Dividend Yield
- NNDM N/A
- ALT N/A
- EPS Growth
- NNDM N/A
- ALT N/A
- EPS
- NNDM N/A
- ALT N/A
- Revenue
- NNDM $57,660,000.00
- ALT $20,000.00
- Revenue This Year
- NNDM $26.79
- ALT N/A
- Revenue Next Year
- NNDM N/A
- ALT N/A
- P/E Ratio
- NNDM N/A
- ALT N/A
- Revenue Growth
- NNDM 6.85
- ALT N/A
- 52 Week Low
- NNDM $2.04
- ALT $5.14
- 52 Week High
- NNDM $3.00
- ALT $11.16
- Technical
- Relative Strength Index (RSI)
- NNDM 39.29
- ALT 33.93
- Support Level
- NNDM $2.10
- ALT $5.15
- Resistance Level
- NNDM $2.22
- ALT $6.09
- Average True Range (ATR)
- NNDM 0.09
- ALT 0.42
- MACD
- NNDM -0.00
- ALT -0.06
- Stochastic Oscillator
- NNDM 29.27
- ALT 3.66
About NNDM Nano Dimension Ltd.
Nano Dimension Ltd is a provider of intelligent machines for the fabrication of Additively Manufactured Electronics (AME). High-fidelity active electronic and electromechanical subassemblies are integral enablers of autonomous intelligent drones, cars, satellites, smartphones, and in medical devices. The portfolio of the company includes Mechanical, Chemical, Applications, Industrial Design, and Artificial Learning areas. Nano Dimension machines serve cross-industry needs by depositing proprietary consumable conductive and dielectric materials simultaneously, while concurrently integrating in-situ capacitors, antennas, coils, transformers, and electromechanical components, to function at an unprecedented performance.
About ALT Altimmune Inc.
Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.